Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 26, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Hoang Downgraded (SRPT) to Hold and Increased Target to $176 on, Jun 26th, 2024
David Hoang of Citigroup, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold and Increased Target from $172 to $176 on, Jun 26th, 2024.
David has made no other calls on SRPT in the last 4 months.
There are 15 other peers that have a rating on SRPT. Out of the 15 peers that are also analyzing SRPT, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Hold with Increased Target to $185 on, Monday, June 24th, 2024
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $128 on, Friday, June 21st, 2024
- Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $182 on, Friday, June 21st, 2024
These are the ratings of the 12 analyists that currently disagree with David
- Mani Foroohar of "Leerink Partners" Maintained at Buy with Increased Target to $230 on, Monday, June 24th, 2024
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $213 on, Friday, June 21st, 2024
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $226 on, Friday, June 21st, 2024
- Gil Blum of "Needham" Maintained at Strong Buy with Increased Target to $235 on, Friday, June 21st, 2024
- Biren Amin of "Piper Sandler" Maintained at Buy and Held Target at $157 on, Friday, June 21st, 2024
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $200 on, Friday, June 21st, 2024
- Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $179 on, Friday, May 17th, 2024
- Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Tuesday, May 14th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $175 on, Friday, May 3rd, 2024
- Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $167 on, Friday, March 1st, 2024
